enVVeno Medical Corporation (NVNO)
NCM – Real vaqt narxi. Valyuta: USD
10.59
+0.08 (0.76%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
10.59
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 4:10 PM EDT

NCM – Real vaqt narxi. Valyuta: USD
10.59
+0.08 (0.76%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
10.59
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 4:10 PM EDT
enVVeno Medical Corporation, klinik bosqichdagi tibbiy qurilmalar ishlab chiqaruvchi kompaniya, venoz kasalliklarni davolashda standartlarni yaxshilash uchun biotizimli to'qimalarga asoslangan echimlarni ishlab chiqishga qaratilgan. Kompaniyaning asosiy mahsuloti - bu VenoValve, surunkali venoz etishmovchilikni davolash uchun venoz klapan almashtirish. Uning VenoValve kompaniyasi yuqori sonning 5-6 dyuymli kesmasi orqali ochiq jarrohlik amaliyoti orqali bemorning femoral venasiga implantatsiya qilinadi. Kompaniya shuningdek, enVVe klapanini, enVVe etkazib berish tizimini va etkazib berish tizimi aksessuarlarini o'z ichiga olgan enVVe, jarrohliksiz va transkateterli venoz klapan almashtirish tizimini ishlab chiqadi. Kompaniya ilgari Hancock Jaffe Laboratories, Inc. nomi bilan tanilgan va 2021-yil oktyabr oyida enVVeno Medical Corporation nomini o'zgartirgan. enVVeno Medical Corporation 1999-yilda tashkil etilgan va Kaliforniyaning Irvin shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Hamed Alavi Ph.D. | Senior VP & Chief Technology Officer |
| Dr. Marc H. Glickman M.D. | Senior VP & Chief Medical Officer |
| Mr. Robert A. Berman | CEO & Director |
| Ms. Jennifer Bright CPA | Chief Financial Officer |
| Ms. Sandy Prietto | Vice President of Marketing |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-01-20 | 8-K | form8-k.htm |
| 2025-12-12 | 8-K | form8-k.htm |
| 2025-12-02 | DEFR14A | ny20059625x2_defr14a.htm |
| 2025-11-20 | 8-K | form8-k.htm |
| 2025-11-19 | PRER14A | ny20059625x1_prer14a.htm |
| 2025-11-14 | 8-K | form8-k.htm |
| 2025-10-30 | 8-K | form8-k.htm |
| 2025-10-10 | 8-K | form8-k.htm |
| 2025-08-20 | 8-K | form8-k.htm |
| 2025-07-31 | 10-Q | form10-q.htm |